Literature DB >> 15767947

[Institutional communication on SARS: a public health tool].

N Postel-Vinay, J Chemardin.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15767947      PMCID： PMC7134903          DOI： 10.1016/s0761-8425(04)71577-6

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN： 0761-8425            Impact factor:   0.622


× No keyword cloud information.
  7 in total

1.  Faster... but fast enough? Responding to the epidemic of severe acute respiratory syndrome.

Authors:  Julie Louise Gerberding
Journal:  N Engl J Med       Date:  2003-04-02       Impact factor: 91.245

2.  Explosion of internet advertisements for protection against SARS.

Authors:  Fred Charatan
Journal:  BMJ       Date:  2003-04-26

3.  Ethical and legal challenges posed by severe acute respiratory syndrome: implications for the control of severe infectious disease threats.

Authors:  Lawrence O Gostin; Ronald Bayer; Amy L Fairchild
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

4.  SARS, the Internet, and the Journal.

Authors:  Jeffrey M Drazen; Edward W Campion
Journal:  N Engl J Med       Date:  2003-05-15       Impact factor: 91.245

5.  Planning for epidemics--the lessons of SARS.

Authors:  Robert A Weinstein
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

6.  Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003.

Authors:  Xinghuo Pang; Zonghan Zhu; Fujie Xu; Jiyong Guo; Xiaohong Gong; Donglei Liu; Zejun Liu; Daniel P Chin; Daniel R Feikin
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

7.  [On the next world influenza epidemic].

Authors:  P Léophonte
Journal:  Rev Mal Respir       Date:  2004-12       Impact factor: 0.622
  7 in total
  2 in total

Review 1.  [Asymptomatic forms of the Severe Acute Respiratory Syndrome (SARS)].

Authors:  M André; F Talarmin; P Le Guen; X Nicolas; J F Garcia; F Natali
Journal:  Rev Mal Respir       Date:  2005-02       Impact factor: 0.622

2.  [On the next world influenza epidemic].

Authors:  P Léophonte
Journal:  Rev Mal Respir       Date:  2004-12       Impact factor: 0.622
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.